The pioneering work of Whipple in 1945' began an era of portosystemic shunt surgery for portal hypertension which remained the primary form of treatment for nearly 30 years even though the consequences of portal diversion such as liver atrophy and encephalopathy were soon recognised.2 Repeated trials in patients with bleeding varices confirmed that the complications of medical management were related to recurrent bleeding whereas surgical treatment was followed by liver failure and encephalopathy. Refinements of surgical technique eventually culminated in the selective shunt procedures developed by Warren et We would therefore suggest that surgery should still be considered for the management of portal hypertension, particularly in the following circumstances:
(1) Uncontrollable bleeding during the initial course of sclerotherapy;
(2) Life threatening haemorrhage from recurrent varices; (3) Bleeding from ectopic varices not accessible to sclerotherapy; (4) Uncontrollable bleeding from oesophageal ulceration secondary to injection sclerotherapy; (5) Severe, symptomatic hypersplenism; (6) For patients who live in communities remote from blood transfusion facilities and adequate medical care.
The management of the complications of portal hypertension continues to pose problems. We believe that the best results should come from a combined management approach using injection sclerotherapy as primary treatment and surgery for complications and for haemorrhage from unusual anatomical sites. 
